Profil
Michel Gardet is currently a Director at Phagenesis Ltd. He was formerly a Director at Glycom A and Global Head-Business Operations at Nestle Health Science SA.
Aktive Positionen von Michel Gardet
| Unternehmen | Position | Beginn |
|---|---|---|
Phagenesis Ltd.
Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat patients suffering from neurogenic dysphagia | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michel Gardet
| Unternehmen | Position | Ende |
|---|---|---|
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Geschäftsführer | - |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Health Technology |
Phagenesis Ltd.
Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat patients suffering from neurogenic dysphagia | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
















